Key result
Higher pre-procedural NT-proBNP linked to ~4% higher AF recurrence risk per 100 pg/mL after cryoablation.
Why the study?
NT-pro-BNP may reflect AF disease progression and comorbidities influencing success after pulmonary vein isolation, but its association with long-term outcome after first-ever cryo-PVI required evaluation.
Does pre-procedural serum NT-pro-BNP level predict long-term recurrence of atrial fibrillation in patients undergoing primary cryoballoon pulmonary vein isolation?
Cohort (n=374)
No
Does pre-procedural serum NT-pro-BNP level predict long-term recurrence of atrial fibrillation in patients undergoing primary cryoballoon pulmonary vein isolation?
Pre-procedural serum NT-pro-BNP is an accessible biomarker that correlates with left atrial pressure and independently predicts long-term AF recurrence over 3.8 years following primary cryoballoon pulmonary vein isolation.
Answers are grounded in this paper and cite their sources.
May support pre-procedural risk stratification for AF recurrence after cryoballoon PVI; leaves open prospective validation before clinical adoption.
NT-pro-BNP is produced in the cardiac atria and ventricles in response to increased wall stress. It may be a marker of both AF disease progression and co-morbidities that affect success after pulmonary vein isolation (PVI). This single-center retrospective study analyzed the association between pre-procedural NT-pro-BNP serum levels and the long-term outcome after a first-ever PVI in cryo-technique. Patients were followed by searching the hospital information system and conducting structured telephone interviews. Treatment failure was defined as any relapse of atrial fibrillation (AF) occurring 90 days after the index PVI at the earliest. Kaplan−Meier survival curves and Cox proportional hazards models were computed to assess the impact of NT-pro-BNP on AF recurrence. Following 374 patients over a median of 3.8 years (range: 0.25−9.4 years), baseline NT-pro-BNP was associated with the combined endpoint in univariate analysis (HR 1.04 per 100 pg/mL increase, 95% CI: 1.02−1.07, p < 0.001). Results were virtually unchanged in the multivariate model or if the data were log-transformed. Intraprocedural left atrial pressure correlated positively with log NT-pro-BNP. NT-pro-BNP was associated with AF relapse during a long-term follow-up after first-ever cryo-PVI in our cohort of patients with predominantly normal left ventricular function. This lab parameter is easy to obtain and has significant potential to guide treatment decisions.
No takes yet. Share an insight, caveat, or question.
Blessberger et al. (2022) conducted a cohort in Paroxysmal or persistent atrial fibrillation undergoing primary cryoballoon pulmonary vein isolation (n=374). Pre-procedural serum NT-pro-BNP level vs. Lower baseline serum NT-pro-BNP levels (evaluated continuously per 100 pg/mL increase and across tertiles) was evaluated on Combined endpoint of any AF relapse occurring after a 90-day blanking period (AF, atrial flutter, or atrial tachycardia >30 s documented on 12-lead ECG, requiring cardioversion, requiring hospital admission, or requiring re-do PVI) (HR 1.04 per 100 pg/mL increase, 95% CI 1.02-1.07, p=< 0.001). Higher pre-procedural NT-pro-BNP levels predicted increased risk of atrial fibrillation recurrence after first-ever cryoballoon pulmonary vein isolation.
Synapse has enriched 10 related papers. Consider them for comparative context: